Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07398261 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Sep 1, 2026 → Nov 1, 2026
See other at-risk trials from Menoufia University

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 28, 2023 to Nov 28, 2023
    • Primary completion pushed from Sep 1, 2026 to Nov 1, 2026
    • Eligibility criteria expanded, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase 3 clinical trial will compare use of individual treatment with mirabegron or desmopressin and their combination for treatment of non-monosymptomatic nocturnal enuresis in children
Trial Details
NCT Number NCT07398261
Lead Sponsor Menoufia University
Conditions
(from sponsor)		 Treatment of Non-monosymptomatic Nocturnal Enuresis
Enrollment 151 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov